Volrustomig is under clinical development by AstraZeneca and currently in Phase ...
IBI-322 is under clinical development by Innovent Biologics and currently in Pha...
The drug is a monthly injection for a genetic disorder called ATTR-PN, which aff...
This week on "The Readout LOUD": What does it mean to a bad CEO? Can biotech end...
At least 116 million individuals were impacted by large and numerous health data...
Understand how science, health policy, and medicine shape the world everyday. Si...
Want to stay on top of the science and politics driving biotech today? Sign up t...
The FDA rejected Merck's treatment for chronic cough, saying the application "di...
A new study examines tools that pharma companies use to keep drug prices high an...
It isn't just obesity — chronic liver disease is also an increasing problem in t...
Medical marijuana companies sell medicine, just like pharma companies. But a STA...
As STAT looks back at 2023 in photographs, the faces of so many stand out.
Why haven’t health care cost increases exceeded inflation in recent years? There...
Congress gave the FDA more power to get companies to racially diversify clinical...
“Those two caricatures that they put on national TV is how people view us,” an a...
The Securities and Exchange Commission charged Laura Perryman, former CEO of med...
